Advertisement
Advertisement

ETON

ETON logo

Eton Pharmaceutcials, Inc. Common Stock

36.61
USD
Sponsored
-0.72
-1.93%
Jul 10, 15:59 UTC -4
Closed
exchange

After-Market

36.67

+0.06
+0.18%

ETON Earnings Reports

Positive Surprise Ratio

ETON beat 12 of 28 last estimates.

43%

Next Report

Date of Next Report
Aug 06, 2026
Estimate for Q2 26 (Revenue/ EPS)
$26.84M
/
$0.10
Implied change from Q1 26 (Revenue/ EPS)
+10.60%
/
+100.00%
Implied change from Q2 25 (Revenue/ EPS)
+41.80%
/
-200.00%

Eton Pharmaceutcials, Inc. Common Stock earnings per share and revenue

On May 14, 2026, ETON reported earnings of 0.05 USD per share (EPS) for Q1 26, missing the estimate of 0.09 USD, resulting in a -45.53% surprise. Revenue reached 24.27 million, compared to an expected 22.76 million, with a 6.63% difference. The market reacted with a +1.00% price change (close before vs. close after earnings).
Looking ahead to Q2 26, -- analysts forecast an EPS of 0.10 USD, with revenue projected to reach 26.84 million USD, implying an increase of 100.00% EPS, and increase of 10.60% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Replimune Group, Inc.
Report Date
Jun 29, 2026 For Q4 26
Estimate
-$0.72
Actual
-$0.76
Surprise
-4.52%
FAQ
For Q1 2026, Eton Pharmaceutcials, Inc. Common Stock reported EPS of $0.05, missing estimates by -45.53%, and revenue of $24.27M, 6.63% above expectations.
The stock price moved up 1%, changed from $29.96 before the earnings release to $30.26 the day after.
The next earning report is scheduled for Aug 06, 2026.
Based on -- analysts, Eton Pharmaceutcials, Inc. Common Stock is expected to report EPS of $0.10 and revenue of $26.84M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement